HAIRPIN RIBOZYME--FOLDING, STRUCTURE, AND MECHANISM
Project Number5R01AI044186-04
Contact PI/Project LeaderBURKE, JOHN MACKENZIE
Awardee OrganizationUNIVERSITY OF VERMONT & ST AGRIC COLLEGE
Description
Abstract Text
An integrated series of biochemical, biophysical, and combinatorial experiments is designed to answer three fundamental questions concerning the hairpin ribozyme: First, how does the RNA assemble into a catalytic structure? Second, what is the structure of the ribozyme-substrate complex? Third, how does this structure result in the acquisition of catalytic activity? The hairpin ribozyme is well suited to such experiments, since the molecule is small enough that comprehensive studies can be undertaken, yet complex enough that significant conformational changes occur during the catalytic cycle. The hairpin differs in several important respects from the only two RNA enzymes that have been more extensively studied, the hammerhead ribozyme and group I introns. Specific Aims are: (1) Map the tertiary structure of the ribozyme-substrate complex; (2) Determine the mechanisms through which metal ions and inhibitors modulate catalytic activity; (3) Define the folding pathway and determine the requirements, kinetics, and thermodynamics of folding and unfolding; (4) Determine the tertiary structure of the ribozyme- substrate complex at high resolution; and (5) Integrate results to develop and test models of the catalytic mechanism. The importance of this work includes advancement of our understanding of RNA structure and how it leads to catalytic activity, the role of catalytic RNA and RNP in biological reactions, and the application of our understanding of catalytic RNA and ribozyme engineering to improving heath, through identifying gene function in genomic investigations and the development of selective ribozyme-based therapeutics for genetic and viral diseases.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
066811191
UEI
Z94KLERAG5V9
Project Start Date
01-December-1998
Project End Date
30-November-2003
Budget Start Date
01-December-2001
Budget End Date
30-November-2002
Project Funding Information for 2002
Total Funding
$439,331
Direct Costs
$291,926
Indirect Costs
$147,405
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Allergy and Infectious Diseases
$439,331
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI044186-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI044186-04
Patents
No Patents information available for 5R01AI044186-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI044186-04
Clinical Studies
No Clinical Studies information available for 5R01AI044186-04
News and More
Related News Releases
No news release information available for 5R01AI044186-04
History
No Historical information available for 5R01AI044186-04
Similar Projects
No Similar Projects information available for 5R01AI044186-04